Sales for the period ending March 31, 2025, also saw robust growth, climbing 21% year-on-year to EGP 599.979 million (US$ 19.4 million).
The company’s authorized capital will remain unchanged at US$7 million, while the issued capital will double, increasing the number of shares to 1,400,027,312, each with a nominal value of EGP 0.20 (US$0.004).
The group has received the U.S. Food and Drug Administration (FDA) certification, which is essential for entering the highly regulated U.S. market.
Total wheat consumption in 2025-26 is expected to reach 20.4 million tonnes, which would be up nearly 1.5% from 2024-25.
The Egyptian Commodity Exchange is designed to serve as a gateway for both importing and exporting.